New Zealand's Medsafe Decides To Leave Voltaren NSAID Drug On Market
This article was originally published in PharmAsia News
Executive Summary
New Zealand's Medsafe has decided to leave the Novartis painkiller Voltaren (diclofenac) on the local market despite moves by other countries, such as Canada and the UK, to order recalls.